GC Biopharma Corp. (KRX:006280)

South Korea flag South Korea · Delayed Price · Currency is KRW
131,400
-1,000 (-0.76%)
Feb 20, 2025, 9:00 AM KST
11.64%
Market Cap 1.52T
Revenue (ttm) 1.64T
Net Income (ttm) -18.85B
Shares Out 11.41M
EPS (ttm) -1,652.01
PE Ratio n/a
Forward PE 40.56
Dividend 1,500.00 (1.14%)
Ex-Dividend Date Dec 27, 2024
Volume 47,506
Average Volume 50,086
Open 132,500
Previous Close 132,400
Day's Range 131,200 - 132,500
52-Week Range 108,600 - 181,800
Beta 0.97
RSI 37.46
Earnings Date Feb 14, 2025

About GC Biopharma

GC Biopharma Corp., a biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally. It provides over-the-counter drugs, such as Acustop Cataplasma for Analgesic and anti-inflammatory effect; Kenhancer plaster for anti-inflammatory; and Zenol Cool Type and Zenol Mild Hot Type drugs to treat anti-inflammatory and pain relief. The company also offers Albumin-GCC injection (inj.) for hypoalbuminemia and shock in acute hemorrhage, as well as low synthesis of albumin; Antithrombin-III (AT-III) inj. for heredit... [Read more]

Sector Healthcare
Founded 1967
Employees 2,009
Stock Exchange Korea Stock Exchange
Ticker Symbol 006280
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.